Literature DB >> 11988105

Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells.

Michael Guppy1, Peter Leedman, XinLin Zu, Victoria Russell.   

Abstract

For the past 70 years the dominant perception of cancer metabolism has been that it is fuelled mainly by glucose (via aerobic glycolysis) and glutamine. Consequently, investigations into the diagnosis, treatment and the basic metabolism of cancer cells have been directed by this perception. However, the data on cancer metabolism are equivocal, and in this study we have sought to clarify the issue. Using an innovative system we have measured the total ATP turnover of the MCF-7 breast cancer cell line, the contributions to this turnover by oxidative and glycolytic ATP production and the contributions to the oxidative component by glucose, lactate, glutamine, palmitate and oleate. The total ATP turnover over approx. 5 days was 26.8 micromol of ATP.10(7) cells(-1).h(-1). ATP production was 80% oxidative and 20% glycolytic. Contributions to the oxidative component were approx. 10% glucose, 14% glutamine, 7% palmitate, 4% oleate and 65% from unidentified sources. The contribution by glucose (glycolysis and oxidation) to total ATP turnover was 28.8%, glutamine contributed 10.7% and glucose and glutamine combined contributed 40%. Glucose and glutamine are significant fuels, but they account for less than half of the total ATP turnover. The contribution of aerobic glycolysis is not different from that in a variety of other non-transformed cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988105      PMCID: PMC1222574          DOI: 10.1042/bj3640309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Differences in fuel utilization between trout and human thrombocytes in physiological media.

Authors:  M Guppy; D J Hill; P Arthur; A F Rowley
Journal:  J Comp Physiol B       Date:  1999-10       Impact factor: 2.200

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Positron emission tomography in breast cancer: a clinicopathological correlation of results.

Authors:  A Y Rostom; J Powe; A Kandil; A Ezzat; S Bakheet; F el-Khwsky; G el-Hussainy; R Sorbris; O Sjoklint
Journal:  Br J Radiol       Date:  1999-11       Impact factor: 3.039

4.  Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines.

Authors:  J W Kim; T E Kim; Y K Kim; Y W Kim; S J Kim; J M Lee; I K Kim; S E Namkoong
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-12

5.  Substrate oxidation and ATP supply in AS-30D hepatoma cells.

Authors:  S Rodríguez-Enríquez; M E Torres-Márquez; R Moreno-Sánchez
Journal:  Arch Biochem Biophys       Date:  2000-03-01       Impact factor: 4.013

6.  Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate.

Authors:  A Singh; A Purohit; H A Hejaz; B V Potter; M J Reed
Journal:  Mol Cell Endocrinol       Date:  2000-02-25       Impact factor: 4.102

7.  Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis.

Authors:  K Yutani; E Shiba; H Kusuoka; M Tatsumi; T Uehara; T Taguchi; S I Takai; T Nishimura
Journal:  J Comput Assist Tomogr       Date:  2000 Mar-Apr       Impact factor: 1.826

8.  Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.

Authors:  S Chang; S Lee; C Lee; J I Kim; Y Kim
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

Review 9.  The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Authors:  J M Brown
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

Review 10.  Positron emission tomography as a diagnostic tool in oncology.

Authors:  C Schiepers; C K Hoh
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

View more
  99 in total

1.  Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo.

Authors:  Adonia E Papathanassiu; Nicholas J MacDonald; David R Emlet; Hong A Vu
Journal:  Cell Stress Chaperones       Date:  2010-10-07       Impact factor: 3.667

2.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

3.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

Review 4.  Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.

Authors:  Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Anthony Howell; Richard G Pestell; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Int J Biochem Cell Biol       Date:  2011-02-15       Impact factor: 5.085

Review 5.  Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.

Authors:  Lidia de Bari; Anna Atlante
Journal:  Cell Mol Life Sci       Date:  2018-05-04       Impact factor: 9.261

Review 6.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

Authors:  Jie Zheng
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

8.  Regulation of the Warburg effect in early-passage breast cancer cells.

Authors:  Ian F Robey; Renu M Stephen; Kathy S Brown; Brenda K Baggett; Robert A Gatenby; Robert J Gillies
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

10.  Beta-catenin is involved in alterations in mitochondrial activity in non-transformed intestinal epithelial and colon cancer cells.

Authors:  M Mezhybovska; Y Yudina; A Abhyankar; A Sjölander
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.